Top Wall Street analysts see robust growth potential in these 3 stocks

Wall Street analysts turned more constructive on three AI-linked names: Datadog, Micron, and Lam Research. Datadog’s price target was raised to $260 from $225 after a strong Q1 and a >30% Q2 revenue growth outlook, while Micron’s target jumped to $1,625 from $535 as UBS raised 2027-2029 EPS estimates and cited memory LTAs and AI-driven demand. Lam Research also saw a target increase to $380 from $330 on stronger WFE spending assumptions, with analysts pointing to upside from semiconductor capex and node transitions.

Analysis

The market is shifting from "AI hope" to "AI plumbing" monetization: observability, memory, and wafer-fab tools are the cleaner second-order beneficiaries because every incremental AI dollar spent by hyperscalers and enterprises creates recurring demand for monitoring, capacity, and process control. That argues for staying long the picks-and-shovels stack rather than the model layer, where pricing is still less visible and competitive intensity remains higher. The key subtlety is that these winners have different elasticity profiles: DDOG benefits from complexity-driven seat expansion, MU from a structural repricing of memory as a contracted utility, and LRCX from capex pull-through with a lag.

MU is the highest-quality expression because the thesis is no longer cyclical spot pricing alone; long-duration fixed-volume agreements can compress near-term upside volatility while materially lowering the probability of a downcycle. The market is likely underappreciating how contract structure changes the earnings distribution: lower peak margins, but much higher trough floors, which should justify a higher multiple and reduce the discount rate investors apply to forward EPS. The main risk is that the market extrapolates too aggressively into 2027-2029 and ignores that memory is still ultimately tied to customer digestion and AI server build rates.

LRCX is the most direct beta to a delayed capex wave, but the timing matters: foundry and memory customers can defer tool receipts for quarters even when their strategic budgets are unchanged. That creates an attractive 6-12 month setup if spend revisions continue, but also a vulnerability if TSMC/Samsung/Micron capex gets pushed out or if node-transition spending proves less incremental than expected. DDOG is the cleanest near-term earnings momentum name, yet it is also the most exposed to any pause in enterprise software scrutiny if CFOs decide to optimize AI observability spend after initial deployments.

The contrarian angle is that the consensus may be right on direction but wrong on sequence: the trade is not "AI is broadening," it is "AI is lengthening cycles and concentrating share in vendors with contractual or mission-critical leverage." That favors owning the names where revenue visibility improves faster than the market model updates. If the AI capex cycle stays intact for another 2-3 quarters, the bigger risk is not an AI bubble burst but a crowded factor unwind in the obvious winners once estimates finally catch up.

Key Decisions for Investors

• Long MU into the next 2-3 earnings prints; target a 6-9 month hold. Best risk/reward in the group because contract visibility can re-rate the multiple even if spot memory pricing cools; trim only if consensus EPS revisions stop rising for two consecutive quarters.
• Add DDOG on any post-earnings or macro-driven weakness over the next 4-8 weeks. Use it as a quality growth compounder with beat-and-raise optionality; risk is multiple compression if enterprise spend scrutiny broadens, so size modestly versus MU.
• Long LRCX vs short a basket of less-levered semi equipment names such as AMAT/MKSI on a 3-6 month horizon. The pair isolates upside from AI-driven WFE re-acceleration while reducing exposure to a general semiconductor beta de-rating.
• Buy MU call spreads 6-12 months out rather than outright equity if implied vol remains reasonable. This captures continued multiple expansion while defining downside if the market starts fading the 2027-2029 EPS step-up narrative.
• Set a tactical take-profit on LRCX after the next capex guide-up cycle; this is a sentiment-sensitive trade where the stock can outrun fundamentals once consensus revisions fully bridge to the revised WFE outlook.